Skip to main content
mBio logoLink to mBio
. 2021 Sep 7;12(5):e01785-21. doi: 10.1128/mBio.01785-21

The Emergence and Zoonotic Transmission of H10Nx Avian Influenza Virus Infections

Holly Everest a,b, Elizabeth Billington a,c, Rebecca Daines a,d, Alice Burman a,d, Munir Iqbal a,
Editors: Rohit K Jangrae, Vinayaka R Prasadf
PMCID: PMC8546645  PMID: 34488450

ABSTRACT

Avian influenza viruses pose a continuous threat to both poultry and human health, with significant economic impact. The ability of viruses to reassort and jump the species barrier into mammalian hosts generates a constant pandemic threat. H10Nx avian viruses have been shown to replicate in mammalian species without prior adaptation and have caused significant human infection and fatalities. They are able to rapidly reassort with circulating poultry strains and go undetected due to their low pathogenicity in chickens. Novel detections of both human reassortant strains and increasing endemicity of H10Nx poultry infections highlight the increasing need for heightened surveillance and greater understanding of the distribution, tropism, and infection capabilities of these viruses. In this minireview, we highlight the gap in the current understanding of this subtype and its prevalence across a vast range of host species and geographical locations.

KEYWORDS: avian influenza, avian viruses, H10Nx, pandemic, poultry, reassortment, zoonotic

INTRODUCTION

Influenza A viruses (IAV), which include avian influenza viruses (AIV), are members of the family Orthomyxoviridae and are negative-sense, single-stranded viruses containing a segmented RNA genome. Each genome consists of eight viral RNA (vRNA) segments enveloped in a host-derived lipid membrane with two surface glycoproteins: hemagglutinin (HA) and neuraminidase (NA). Variations in antigenicity and phylogenetics of the HA and NA proteins allow their characterization into subtypes, designated H(x)N(y). Eighteen HA subtypes and 11 NA subtypes have so far been identified. Individual isolates are named according to the following pattern: antigenic type (A, B, C, or D), host of origin, geographical location, strain number, and year of isolation (1). This is then succeeded by H(x)N(y). Where the host of isolation is human, the host of origin is excluded from the strain name.

The primary natural host reservoir of IAVs is wild aquatic birds (predominately Anseriformes) (2, 3) with the exception of H17 and H18 subtype viruses isolated only from bats (4, 5). AIVs may also cause sporadic incursions in domestic poultry, humans, and other mammalian species (6, 7). The recent identification of a novel reassortant H10N3 virus in humans has reignited concerns regarding the pandemic potential of the H10 influenza subtype (8). H10 viruses with nine NA subtypes have been isolated from various hosts. However, all have been wild bird derived and evolved to infect both terrestrial poultry and mammalian species.

AIVs can be classified into two pathotypes both by molecular signature within their HA segment and as a result of clinical disease in chickens, referred to as low-pathogenicity avian influenza virus (LPAIV) and high-pathogenicity avian influenza virus (HPAIV) (9). Specifically, a virus is considered an HPAIV if it has an intravenous pathogenicity index (IVPI) score in 6-week-old chickens greater than 1.2 or causes at least 75% mortality in 4- to 8-week-old chickens when birds are infected intravenously (10, 11). The virus is also considered an HPAIV if there is a polybasic cleavage site in the HA segment and endogenous furin-like proteases activate the HA at polybasic cleavage sites to facilitate a systemic, and often fatal, infection. Only subtypes H5 and H7 have displayed this phenotype in natural isolates. However, an H10 isolate (A/Mandarin duck/Singapore/805/F-72/7/1993) was found to be highly pathogenic via in vivo testing procedures despite H10 AIVs not usually being associated with high pathogenicity (12). A point to note is that the virus was atypical of HPAIVs in that it was not pathogenic when administered intranasally and did not possess a polybasic cleavage site. It also did not replicate in the brains of chickens after intravenous inoculation. An earlier H10 isolate (A/Turkey/England/384/79) suggested that it also had similarly pathogenicity and that the pathogenicity may be attributed to replication in the kidney (12). Absence of the polybasic cleavage site usually classifies the virus as being LPAIV (13, 14), but the presence of di- or tribasic cleavage sites can lead to enhanced pathogenicity (15). LPAIV typically causes milder clinical disease in poultry, often associated with high morbidity (>50%) and low mortality (<5%) (16, 17). However, in some cases of LPAIV infection, mortality can increase, depending on the host susceptibility as well as instances of concurrent or secondary infection with other diseases (16, 18, 19).

While there have been cases in avian species of infection with all nine H10 subtypes, only H10N8 (20), H10N7, and more recently H10N3 (8) have been detected in humans. Zoonotic transmission events are fairly infrequent, and the resulting human infections have raised concerns over virus origin, evolution, and potential human-human transmission. The emergence and prevalence of H10 viruses in both chickens and the occurrence of human infections provide direct evidence of the threat from currently circulating H10Nx infections.

HISTORY AND EMERGENCE OF H10Nx VIRUSES

History of H10Nx isolation and detection.

The H10 subtype has been isolated from both terrestrial avian species and wild and domestic aquatic birds globally. The first detection of H10 subtype viruses was in chickens in Germany in 1949 [A/Chicken/Germany/N/1949 (H10N7)]. The first detection of H10Nx infection outside Europe was in North America, specifically in Canada, in 1953 [A/Duck/Manitoba/1953 (H10N7)].

Species and geographical distribution of H10Nx viruses.

H10Nx infections are enzootic in both poultry and wild bird populations globally. They also continuously circulate in live-bird markets (LBMs) in Asia. Surveillance studies have indicated that terrestrial poultry were the root cause of H10Nx zoonotic transmission events in China beginning in 2012 (2022). H10Nx viruses have a broad host range and are capable of reassorting with increased fitness for mammalian species (23).

Global surveillance of H10Nx viruses.

While surveillance for notifiable AIV subtypes (H5 and H7) is common practice, for neglected subtypes, including H10Nx, surveillance is typically poor. Surveillance of AIV is often limited to subtype prevalence in bird populations based on sequences of HA and NA glycoproteins, but some studies are able to investigate internal genes to examine viral evolution and possible virulence factors (2426). Internal viral genes are sequenced to determine presence of zoonotic risk mutations or virulence markers of specific segments (27) or to track the reassortment of internal genes (24, 25, 28), which is of particular importance for H10Nx infections, as they have been shown to frequently reassort with other circulating subtypes. In many parts of the world, surveillance is conducted in response to disease outbreaks rather than being a long-term project (25), which can make it hard to elucidate long-term trends. Long-term general AIV surveillance has shown that migratory birds have introduced H10 viruses into terrestrial poultry populations, which have caused sustained outbreaks, resulting in identification of numerous reassortant viruses (29) (Table 1).

TABLE 1.

All H10 HA sequences currently available on www.fludb.org, with the corresponding years of detection and sampling sourcesa

Country Period Subtype Species No. of strains Total
Argentina 2011 H10N7 Silver teal, yellow-billed pintail 2 2
Australia 2010 H10N7 Human 2 3
1972 H10N8 Shearwater 1
Bangladesh 2019 H10N3 Duck (unspecified) 2 11
2019 H10N4 Duck (unspecified) 2
2015 H10N6 Duck (unspecified) 1
2009 H10N7 Chicken, duck (unspecified) 4
2010 H10N9 Duck (unspecified) 2
Belgium 2018 H10N1 Mallard 1 3
2016–2017 H10N5 Mallard 2
Canada 1995 H10N1 Mallard 1 46
1978–2013 H10N3 Blue-winged teal, mallard 2
1984–2010 H10N6 American black duck, pintail, mallard 4
1953–2016 H10N7 American black duck, pintail, mallard, blue-winged teal, pintail (unspecified), duck (unspecified), scaup, mallard-black duck hybrid 39
Chile 2016 H10N7 Yellow-billed pintail 3 3
China 2015 H10N1 Duck (unspecified) 1 172
2005–2013 H10N2 Duck (unspecified) 2
2005–2017 H10N3 Duck (unspecified), chicken 39
2003–2014 H10N5 Duck (unspecified), swine, wild bird (unspecified) 11
2005–2014 H10N6 Duck (unspecified), chicken 35
2008–2016 H10N7 Duck (unspecified), goose (unspecified), mallard, chicken 20
2005–2016 H10N8 Duck (unspecified), Environment, chicken, human 63
2013 H10N9 Chicken 1
Egypt 2015 H10N7 Teal (unspecified) 1 1
Germany 1949 H10N7 Bird (unspecified), chicken 3 3
Georgia 2011 H10N4 Mallard 1 6
2010–2014 H10N7 Mallard, duck (unspecified) 5
Hong Kong 1980 H10N5 Mallard 1 6
1979–2009 H10N9 Duck (unspecified), northern shoveler, teal (unspecified) 5
Iceland 2015 H10N7 Black-headed gull, glaucous gull, Iceland gull 4 4
Italy 1965 H10N8 Quail 2 2
Japan 2007 H10N2 Duck (unspecified) 2 12
2013 H10N3 Waterfowl (unspecified) 1
2000–2010 H10N4 Waterfowl (unspecified), duck (unspecified) 3
2008–2014 H10N7 Waterfowl (unspecified), duck (unspecified), mallard 5
2008 H10N9 Waterfowl (unspecified) 1
Mexico 2009 H10N7 Green-winged teal 1 1
Mongolia 2015 H10N2 Mallard, duck (unspecified) 4 29
2001–2015 H10N3 Waterfowl (unspecified), duck (unspecified), mallard 8
2014 H10N6 Waterfowl (unspecified), duck (unspecified) 2
2011–2015 H10N7 Waterfowl (unspecified), mallard 9
2010–2014 H10N8 Waterfowl (unspecified), duck (unspecified) 6
Netherlands 2007 H10N1 Eurasian wigeon 2 32
2006–2008 H10N4 Herring gull, mallard, ruddy turnstone 5
2006 H10N6 Mallard 2
2006–2015 H10N7 Mallard, mute swan 23
Sweden 2007–2009 H10N1 Mallard 20 60
2002 H10N2 Mallard 3
1984–2011 H10N4 Mallard, mink 15
2007 H10N5 Mallard 2
2002–2009 H10N6 Mallard 4
2002–2007 H10N7 Mallard 6
2002–2003 H10N8 Mallard 3
2007 H10N9 Mallard 7
United Kingdom 1985 H10N4 Fowl (unspecified), mallard 2 2
USA 2006–2011 H10N1 Northern shoveler, ruddy turnstone, shorebird, mallard, common goldeneye, red knot 32 824
1987–2018 H10N2 Green-winged teal, laughing gull, shorebird, ruddy turnstone, northern shoveler, common eider, coot, environment, greater scaup, mallard, red knot, shorebird 42
1984–2017 H10N3 American wigeon, blue-winged teal, cinnamon teal, common goldeneye, coot, duck (unspecified), environment, green-winged teal, lesser scaup, mallard, northern shoveler, ruddy turnstone 73
2000–2019 H10N4 Environment, mallard, northern pintail, red knot, ruddy turnstone, shorebird 31
1987–2016 H10N5 Knot (unspecified), ruddy turnstone, mallard, green-winged teal, environment, red knot, gull (unspecified), semipalmated sandpiper, laughing gull, sanderling 96
1989–2014 H10N6 Mallard, American green-winged teal, blue-winged teal, northern shoveler, northern pintail, long-tailed duck, red knot, ruddy turnstone, scoter 11
1979–2019 H10N7 American green-winged teal, black scoter, blue-winged teal, common goldeneye, common murre, duck, environment, Eurasian teal, gadwall, goose (unspecified), greater white-fronted goose, green-winged teal, gull (unspecified), herring gull, laughing gull, lesser scaup, mallard, northern pintail, northern shoveler, quail, red knot, redhead, ruddy turnstone, sanderling, scoter, semipalmated sandpiper, shorebird, turkey 486
2004–2017 H10N8 American green-winged teal, common scoter, environment, green-winged teal, gull (unspecified), laughing gull, long-tailed duck, mallard, northern shoveler, ruddy turnstone, shorebird 29
1996–2016 H10N9 Blue-winged teal, environment, northern shoveler, ruddy turnstone, shorebird 24
Vietnam 2016 H10N6 Duck (unspecified) 1 1
a

Only strains with a specified NA subtype are included.

GENOMIC SEQUENCE AVAILABILITY AND NOMENCLATURE

Availability of sequence data.

As of 15 June 2021, 1,367 full or majority partial (>70% of segment length) HA sequences were publicly available on FluDB (www.fludb.org). Most sequences are from North America (69%; n = 943), of which 94% were sampled in the United States. Additionally, 23% of sequences were sampled in Asia (n = 304), of which 79% (n = 239) were sampled in China. Approximately 8% of H10Nx sequences (n = 113) were sampled in Europe. Lower sequence availability outside the United States and China may partly reflect lower surveillance or reduced sequencing capacity in these regions (30). Increasing global sequencing in these regions for both H10 and other neglected subtypes is important for several reasons, not only to keep track of regional increase in occurrences in domestic poultry but also to identify potential reassortants that could allow cross-species and zoonotic transmission (31).

Nomenclature.

While all AIVs have evolved into distinct lineages, which are typically characterized by geographical distribution, the rapid evolution and persistence of the H5 HA derived from the A/Goose/Guangdong/1996 (H5N1) strain incited the development of a standard clade nomenclature system. Phylogenetic analysis of HA genes characterized sequences into clades based upon sequence homology and specific clade definition criteria. The nomenclature system is relatively fluid; as viruses continue to evolve, new sublineages intermittently emerge until the specific clade definition criteria are met, and they are then assigned as separate clades (32). There is currently no universally recognized or formal nomenclature system for H10 viruses, and the clades that have been widely acknowledged are loosely characterized. Zhuang et al. (33) have proposed that H10 subtypes can be classified into two primary lineages, H10.1 and H10.2, which predominantly correspond with geographic location and AIVs circulating in the Western and Eastern hemispheres, H10.1 being North American and H10.2 referring to Eurasian viruses (33). Phylogenetic analysis of the H10 HA sequences available in the NCBI Influenza Virus Resource Database further confirmed that the H10 viruses can be divided into North American and Eurasian lineages (34). The Eurasian lineage is considered more divergent and has split into multiple sublineages, including European and Asian (JX436-like) (35).

H10Nx VIRUSES IN AVIAN SPECIES

Wild aquatic birds.

Wild birds are the natural host reservoirs of AIVs (36, 37). Avian influenza H10 viruses appear to be endemic in wild bird populations and have been detected globally in Canada, South Korea, Sweden, Italy, the United States, South Africa, and Japan since 1965 (3842). More recently, H10 viruses have developed endemicity in Australian wild aquatic birds and are derived from several viruses circulating in waterfowl along various flyways (43). Their HA gene was derived from aquatic birds in the United States, whereas the NA gene is closely related to that from viruses previously detected in Japan. The remaining genes were derived from Eurasian avian influenza virus lineages. The low pathogenicity of the H10 viruses in birds makes them difficult to detect, allowing the virus to persist and spread; thus, wild birds and poultry can act as large reservoirs for virus maintenance in nature (44, 45).

Domestic poultry.

(i) H10Nx infections in domestic poultry in Asia. (a) China. Active surveillance of AIVs has been ongoing in China for decades in an attempt to control outbreaks in poultry and humans, predominantly driven by live-bird markets (LBMs). Surveillance from 2002 regularly identified H10 in wild and domestic ducks, but this type was not identified in terrestrial poultry until 2013 (20). Since then, H10Nx viruses of multiple subtypes have been detected in domestic and terrestrial poultry with increasing frequency. Three H10Nx subtypes—H10N3, H10N7, and H10N8—were isolated from chickens in Zhejiang Province in eastern China during surveillance of AIVs in live poultry markets in 2016 and 2017 (46). Phylogenetic analysis indicated that these Chinese-isolated viruses received gene segments from H10, H3, and H7 viruses from birds in East Asia.

(b) Bangladesh. H10 AIVs have been frequently isolated with NA subtypes (N1, N6, N7, and N9) in LBMs in Bangladesh (47). Genetic analyses demonstrated that there are two antigenically distinct groups of H10 AIVs are circulating in Bangladeshi LBMs.

(ii) H10Nx infections in domestic poultry in Australia. H10N7 viruses detected in domestic poultry and abattoir workers in Australia in 2010 were found to have an HA gene of North American origin (43). The genomic origins indicated that the H10N7 viruses isolated from poultry were similar to those that have been circulating since 2009 in Australian aquatic birds and that their initial transmission into Australia occurred between 2007 and 2008. While H10Nx viruses have developed endemicity in Australian wild birds, there have been no recent incursions into domestic poultry (43).

H10Nx VIRUSES IN MAMMALIAN SPECIES AND ZOONOTIC INFECTION

H10Nx infections in humans.

In recent years, avian-origin H10 AIVs have proved capable of infecting humans and subsequently pose a potential public health threat (46).

In 2004, H10N7 influenza virus was detected in Egypt (48). Since this detection, the H10N7 AIVs have also caused sporadic human infections with variable clinical symptoms globally. An H10N7 subtype influenza virus (A/Sydney/2/2010) caused infection of poultry abattoir workers in Sydney in 2010 (49). Despite the sporadic incursion of H10N7 human infections, there is limited information pertaining to the molecular characteristics of H10N7 viruses, especially in China (50). An in-depth phylogenetic analysis conducted on chicken isolates by Wu et al. (50) indicated that the viruses contained genetic material from H10, H2, H7, and H3 AIV strains that were circulating at the same time.

Infection with a novel H10N8 influenza virus in humans was first described in China in December 2013. H10 is an LPAIV in avian hosts, allowing undetected circulation and the development of reservoirs (45, 51). An additional risk factor is the frequency of H10Nx reassortment (21, 46). H10Nx viruses have reassorted with enzootic AIV strains, which subsequently caused human infection; an example is that chicken H10N8 viruses identified in China were generated through multiple reassortments between H10 and N8 viruses from domestic ducks and the enzootic chicken H9N2 viruses. H9N2 is an LPAIV; however, it is endemic to much of Asia and the Middle East. There have already been several cases of H9N2 viruses breaching the zoonotic species barrier to infect humans, with this subtype being considered a human pandemic risk (52, 53). H9N2 viruses are also a source of much reassortment within bird populations, with transfer of a H9N2 internal gene cassette being common (54, 55). H7N9 is thought to use H9N2 as a source of reassortment when infected chickens are in close proximity and has subsequently caused a large number of human infections and deaths (55). These H10 chicken reassortant viruses were highly similar to the H10N8 human isolate identified in 2013, indicating that market chickens were the source of this human infection. This novel reassortant virus was confirmed to have originated from an LBM. The first fatal case of H10N8 was identified in a 73-year-old immunocompromised woman in China in 2014. This strain, named JX346, was established as a reassortant with PB1, PB2, PA, NP, M, and NS genes from H9N2. The PB2 gene also harbored mammalian adaptations for enhanced replication (56). The continued reassortment using the H9N2 internal gene cassette suggests that it may be a genetic platform to aid avian strains to cross the species barrier into humans (57).

More recently, the H10 viruses further reassorted, apparently with H5N6 viruses, and generated an H10N6 variant. A recent 2021 reassortant of H10 with N3 subtypes, A/Jiangsu/428/2021 (JX428), also caused human infection in China. Interestingly, the patient had no clear history of exposure to poultry prior to illness onset, based on epidemiological investigation. No avian H10N3 virus has been found in the local surroundings or poultry. Phylogenetic analysis of the novel JX428 isolate revealed it to be a reassortant between H10N3 and H9N2 viruses circulating in 2017 to 2019. HA and PB2 proteins both contain avian adaptation markers, such as 226Q and 627E, respectively. However, PB1 and M1 have adaptation markers linked to increased replication in mammalian cells and increased pathogenicity in mice. This novel H10N3 virus appears to have dual human and avian receptor preference but is unlikely to be transmitted between humans (8).

H10Nx infections in swine.

While wild birds are the natural host reservoir for IAVs, swine are susceptible to infection with both avian and human AIVs. Swine are therefore regarded as the “mixing vessel” for influenza virus reassortants (58). H10N8 specific influenza virus antibodies were detected in swine herds in southern China during routine serological monitoring for swine influenza virus, following the detection of the same virus in humans in 2013. The pathogenicity and transmissibility of this H10N8 influenza virus to swine were examined and demonstrated that swine are susceptible to infection with human-origin H10N8 influenza virus, which causes viral shedding, severe tissue lesions, and seroconversion, while infection with avian-origin H10N8 influenza virus causes only seroconversion and no viral shedding (59). However, human-origin H10N8 influenza virus has inefficient transmission between swine and causes seroconversion only through direct contact (59). An avian-origin H10N5 influenza virus, A/Swine/Hubei/10/2008 (H10N5), was also isolated from pigs in Hubei, China (60). Phylogenetic analysis showed that the strain was wholly of avian origin and closely homologous to the Eurasian/H10.2 lineage viruses. This is regarded as the first report of interspecies transmission of an avian H10N5 influenza virus to domestic pigs under natural conditions (60).

The increasing prevalence of H10Nx viruses in swine highlights the importance of epidemiological monitoring of these H10 IAVs in different animal species, which is crucial in preventing and controlling future H10Nx infections.

H10Nx infections in other mammalian species.

(i) H10Nx infections in mink. The first H10 mammal influenza virus was reported to have been isolated from mink in Sweden in 1984 (61, 62). Six strains of an IAV were isolated from a mink farm, with all six isolates being of the H10 subtype in combination with N4 (62). The unique property of some avian H10 viruses, particularly the ability to cause severe disease in mink without prior adaptation, is of great interest (63). Zohari et al. (48) investigated the influence of different genes on H10 AIV virulence in mink and genomic relationships between H10Nx strains. The genomic relationship between both the mink isolate (A/Mink/Sweden/3900/84) and other H10N4 viruses circulating in avian species at the same time, A/Fowl/Hampshire/378/85 and A/Mallard/Gloucestershire/374/85, showed high similarity between strains. A historic sample was also analyzed, A/Chicken/Germany/N/49, i.e., the H10 prototype virus (H10N7) (64), which demonstrated a weaker genomic relationship, possibly attributed to both virus evolution and reassortment (63). An additional strain, A/Whistling swan/Shimane/468/88 (H10N4), was also included. The H10 isolates presented in this study contained the amino acid sequence PQG|RGLF at the cleavage site in the HA molecule, indicating their low-pathogenicity genotype (48). However, four of these H10 viruses were found to be highly pathogenic in mink. The previously identified H10 isolates A/Turkey/England/384/7 (H10N4) and A/Mandarin duck/Singapore/8058F-72/7/93 (H10N5) (65) fulfil the criteria for high pathogenicity with an IVPI score of >1.2, despite not containing a multibasic cleavage site (65). This suggests that there are factors separate from the presence of multiple basic amino acids in the cleavage site contributing to the severity of H10 viruses in mink.

(ii) H10Nx infections in dogs. H10N8 viruses have also been reported to infect feral dogs in Guangdong Province, China (66). Canine sera collected in March to June 2013 from dogs living near LBMs were found to be reactive to JX346, approximately 6 months before the virus caused the death of a 73-year-old woman. Feral dogs have long-term exposure to birds and poultry entrails at LBMs, which increases their infection risk. Feral dogs may be able to act as sentinels for mammal-adapted viruses before human infection occurs (66).

(iii) H10Nx infections in raccoons. Raccoons have been found to be susceptible to multiple influenza subtypes, including H10, and to seroconvert (67). Raccoons have both α2,3- and α2,6-linked sialic acid cell receptor composition within the respiratory tract and so are susceptible to both human and avian viruses. Raccoons were shown to have H10 antibodies in the United States in 2004 and 2006 (68). Hall et al. (68) also showed that under laboratory conditions, raccoons were able to become infected, to shed virus, and to transmit it to uninoculated animals (68). Due to raccoons’ high mobility and the possibility of coinfection with both human and avian viruses, they are regarded as a possible mixing vessel host that could result in novel reassortant viruses (68).

(iv) H10Nx infections in seals. While H10Nx viruses have been recovered from numerous avian species, there has been sporadic transmission of these H10 viruses into mammals, including seals. Gull-origin H10N7 viruses were isolated in Iceland in 2015, and genomic analysis of these viruses demonstrated that four gene segments in the viruses were genetically associated with H10 IAVs that caused influenza outbreaks and deaths among European seals in 2014 (33, 69, 70).

H10Nx infections in laboratory animals.

Mice are a convenient and relatively inexpensive model in which to study of the mechanisms of influenza virus pathogenesis and human polymerase adaptation. The virulence of four representative H10 AIV strains detected in Bangladeshi LBMs (one from each detected NA subtype) was assessed, and it was found that multiple H10Nx subtype viruses are able to replicate efficiently in mice without prior adaptation (47). Moreover, H10N6 and H10N1 AIVs caused high mortality with systemic dissemination (47). Wu et al. (50) conducted in vivo studies in mice with reassortant H10N7 viruses isolated from poultry in China. These viruses were found to be moderately pathogenic in mice. The viruses were also able to replicate in mice without prior adaptation (50). Mouse inoculation tests conducted by Wu et al. (46) also showed that three H10Nx subtypes—H10N3, H10N7, and H10N8—isolated from chickens in eastern China have low pathogenicity in mice and can efficiently replicate in this species (46).

A study by Lambertz et al. (71) found that H10 pathogenesis in mice is reliant on the presence of TMPRSS2 (transmembrane protease serine 2). TMPRSS2 has been shown to be responsible for the pathogenesis and cleavage of H1 (72) and H7 (73) subtype AIVs in vivo and is key in cleavage of coronavirus spike proteins and subsequent pathogenesis, specifically of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (74). Mice deficient in TMPRSS2 showed no weight loss, no viral replication, and a large reduction in inflammatory lesions within the lung compared to wild-type mice when infected with a H10 HA reassortant virus.

Ferrets are a widely used animal model for human influenza transmission and research, justified by the distribution of sialic acid receptors in the upper respiratory tract, which is similar to that in humans. They also exhibit comparable clinical signs when infected with influenza viruses (7578). Transmission studies in ferrets with gull-origin H10N7 AIVs isolated from Iceland in 2015 demonstrated that the gull-origin viruses could infect ferrets (33) and that the virus could be transmitted between ferrets through both aerosol droplets and direct contact.

These studies demonstrate that H10Nx infections can infect mammals and effectively be transmitted among them without prior adaptation. H10Nx viruses are therefore a candidate for influenza pandemic preparedness and should be monitored in animal species as well as at the animal-human interface (33).

ADAPTATION AND MUTATIONS IN H10Nx VIRUSES

Poultry adaptation.

It is thought that poultry adaptation of IAVs can enhance the potential of an avian virus to cross the species barrier from avian to human (79). A major difference between viruses of terrestrial poultry origin and ancestral duck isolates is their different receptor binding profiles. AIVs are often transmitted from wild waterfowl to domestic poultry through the fecal-oral route (80); however, viruses circulating in different avian species differ in their fine receptor binding specificity and must adapt when switching, for example, from ducks to chickens (81). AIVs can also infect more than 105 bird species, allowing a deep reservoir for spillover events with an abundance of different glycan binding profiles (82). The glycan sugar repertoire in terrestrial poultry differs significantly from that in aquatic birds. Both α2,6- and α2,3-linked sialic acid receptors are present in chickens, specifically in the nasal cavity, upper respiratory tract, and gut, whereas in ducks, α2,3-linked sialic acid outweighs the proportion of α2,6 receptors (8387). During poultry adaptation, the HA evolves; this may induce increased fitness for human receptors (78) but could equally adversely affect the ability of the HA to support virus transmission in humans (30).

A phylogenetic trace of the history of H10N8 viruses suggests that the virus spilled over from wild birds to poultry in southern China (34). An updated analysis showed that H10 HA sequences have not significantly diversified in recent years; however, the emergence of new lineages of internal genes and the global predominance of H9N2 in circulation should be noted due to consistent reassortment of H10Nx viruses (33). Viruses isolated from LBM in Zhejiang in 2016 to 2017 showed evidence of reassortment between H10, H3, and H7 viruses of Eurasian lineages (46). Characterization of H10N8 viruses isolated from Dongting Lake in China showed that polymerase genes were acquired by reassortment with H5 and H7 viruses circulating in Eurasian waterfowl (88). This situation increases the potential for the virus to develop mutations and undergo reassortment, endowing it with high pathogenicity and improved transmissibility to humans (89, 90). These findings also suggest that H10 AIVs have the ability to adapt extremely quickly to terrestrial poultry and highlight the need for long-term surveillance.

Mammalian adaptation.

Upon transmission to a new host, the virus must successfully bind to, enter, and replicate in the host cell as well as evading the innate immune response long enough for egression and then transmission to a new host (30). Consequently, there are a number of factors, all of which are essential, in adaptation to new host species. Certain avian H10Nx viruses have been shown to successfully infect mammalian hosts with minimal or no host adaptation required (45, 46, 91) (Table 2).

TABLE 2.

Mammalian adaptation mutations in H10Nx viruses (H3 numbering)

Protein Strain Subtype Species Infection type Mutation(s) Effect Reference
HA A/Seal/Sweden/SVA0546/2014 H10N7 Seal Natural 351H, 379I, 398D Mammalian adaptation in seals 102
A/Jiangsu/428/2021 H10N3 Human Natural Q226L, E627K Allows binding to both human- and avian-like receptors 8
A/Mallard/Beijing/27/2011 (MA; BJ27-MA) H10N7 Mouse Laboratory G218E Affects both the receptor specificity and the pH of fusion 91
A/Jiangxi-Donghu/346/2013 H10N8 Human Natural A135T, K137R, S138A Mammalian adaptation and increased virulence in HA 45
Q226, S227, G228S Change the binding preference from the α2,3 avian receptor to the α2,6 human receptor.
E190 Allows binding to both human- and avian-like receptors
A/Harbour seal/Netherlands/PV14-221_TS/2015 H10N7 Seal Natural Q226L, T224I, E74D Mammalian adaptation in seals (Q226L); HA stabilization (T224I and E74D) 102
PB2 A/Mallard/Beijing/27/2011 (MA; BJ27-MA) H10N7 Mouse Laboratory E158G Mediates increased virus replication and severity of infection in mice and mammalian cells. 91
M631L Strongly upregulates viral polymerase activity and virus replication and severity in mice and mammalian cells
A/Seal/Sweden/SVA0546/2014 H10N7 Seal Natural 17C, 453S Mammalian adaptation in seals 102
A/Environment/Dongting Lake/Hunan/3-9/2007 H10N8 Environment Natural E627K Enhanced polymerase activity 88
A/Jiangxi-Donghu/346/2013 H10N8 Human Natural E627K Enhanced replication in ferrets and mammalian adaptation 114
A/Duck/Fujian/1761/2010 H10N3 Mouse Laboratory E627K, Q591K Mammalian adaptation and increased virulence in BALB/c mice 35
PB1 A/Seal/Sweden/SVA0546/2014 H10N7 Seal Natural 752D Mammalian adaptation in seals 102
A/Jiangsu/428/2021 H10N3 Human Natural V473D Enhanced polymerase activity and increased replication in mammalian cells 8
PA A/Seal/Sweden/SVA0546/2014 H10N7 Seal Natural 192H Mammalian adaptation in seals 102
M1 A/Jiangxi-Donghu/346/2013 H10N8 Human Natural N30D, T215A When occurring concurrently, increased virulence (as seen in H5N1) 114
A/Jiangsu/428/2021 H10N3 Human Natural 31N, 215A Increased pathogenicity in mice 8
M2 A/Jiangsu/428/2021 H10N3 Human Natural 31S Increased amantadine resistance 8
NS1 A/Jiangxi-Donghu/346/2013 H10N8 Human Natural P42S Increased pathogenicity in mice 114
NA A/Harbour seal/Netherlands/PV14-221_TS/2015 H10N7 Seal Natural 247I, 436T Mammalian adaptation in seals 102
A/Mallard/Beijing/27/2011 (MA; BJ27-MA) H10N7 Mouse Laboratory K110E, S453I Significantly promotes NA enzymatic activity and mammalian adaptation 91

HA structure, HA mutations, and receptor preference.

IAV host adaption is partially dependent on the binding of the viral HA to specific sialic acid isoforms. Avian-like viruses favorably bind sulfated or nonsulfated α2,3 sialic acid isoforms, whereas human influenza viruses preferentially bind the α2,6 isoform (9294). The receptor-binding specificity of IAVs is also a major determinant of virus-host tropism, which allows interspecies transmission (30). H10Nx viruses have different propensities to bind α2,3 or α2,6 sialic acids, depending on lineage and virus origin.

H10 HA crystal structures of human-origin JX34 (H10N8) and avian-like H10N2 showed that H10 is structurally diverse compared to other HA subtypes (95). The residues that are known to modulate receptor preference in other HA subtypes are conserved in the receptor binding site (RBS) of JX34 and avian-like H10N2 HA (95). The JX34 H10HA complex with the human α2,6 isoform displays a 45° difference in the angle of rotation about the Gal-2 C6–C5 bond, which changes the RBS exit trajectory of the human analogue to a less vertical fashion than that seen in pandemic H1 and H3 HA receptor complexes. The human analogues also exit to the side of the H10HA RBS in a trajectory similar to that of a human H7HA-α2,6 isoform cocomplex. This receptor configuration has been correlated with the presence of L226 mutations, commonly seen in human in H7 viruses. However, the H10HA has a Q226 residue, not usually associated with mammalian adaptation. Wang et al. reported that the structure of the JX346 H10HA also bound to avian receptor analogues (45, 60, 9597). The HA RBS of JX346 displays not only the signature Q-S-G residues at positions 226 to 228 (H3 numbering) but also E190, which is indicative of an avian-like HA RBS (98). Additionally, when this virus was serially passaged in embryonated hens’ eggs, no mutations arose. However, when serially passaged in mammalian cell culture (Madin-Darby canine kidney [MDCK] cells), it produced eight point mutations, enforcing the theory of high efficiency for adaptation to avian hosts (99).

Glycan binding preference analysis conducted on gull-origin H10N7 viruses isolated in Iceland in 2015 suggest that, similar to other avian-origin H10 IAVs, the viruses bound to both avian-like α2,3-linked sialic acids and human-like α2,6-linked sialic acids (33). However, when the gull-origin H10N7 viruses were compared to JX346, which caused human infections, the gull-origin viruses showed significantly higher binding affinity to human-like glycan receptors, despite maintaining an avian host (33). Additionally, despite human infection, both JX346 and avian A/Green-winged teal/Texas/Y171/2006 were found to maintain α2,3 binding. As JX346 was not transmitted between human hosts, receptor preference appears to have been the limiting factor (45, 100).

Zhang et al. (100) have identified several key mutations responsible for increased affinity of human and avian-like receptors, including Q226L and/or G228S mutations in wild-type H10Nx viruses. They result in the loss of binding to α2,3 sialosides but do not increase fitness for binding to human-type α2,6 receptors (100).The JX346 virus presented two key residues within the HA which are known as genetic hallmarks for mammalian adaptation and virulence, A135T and S138A (98, 101). H10 has yet to be identified with a multibasic cleavage site, a characteristic of HPAIV, despite some strains exhibiting high pathogenicity in poultry (12).

During serial passage experiments in mice, mutations have arisen in the HA in conjunction with PB2 and NA genes (91). An avian H10N7 outbreak in seals showed mutations in HA to alter receptor binding preference and stability, including the adaptation marker Q226L. In seals, although mutations arose in polymerase subunits, no difference in replication kinetics was found (102). Several seal isolates also had additional point mutations in the HA (351H, 379I, and 398D), contributing to increased fitness for mammalian adaptation.

With the increasing occurrence of H10Nx incursions into mammalian species, HA mutations should be closely monitored, along with continued analysis of the effect these HA mutations have with regard to receptor binding specificity. With the HA protein being responsible for receptor binding and viral entry and, therefore, receptor preference being a major determinant of both host tropism and zoonotic transmission, this is an area that cannot afford to be neglected.

Recent developments.

Phylogenetic analysis of the novel H10N3 A/Jiangsu/428/2021 human isolate (JX428) revealed it to be a reassortant between avian H10N3 and H9N2 viruses circulating in 2017 to 2019. HA and PB2 proteins both contain avian adaptation markers such as 226Q and 627E, respectively, suggesting that it has dual binding specificity of both avian-like and human-like receptors (8). Despite this, this novel H10N3 virus appears to be unlikely to be transmitted between humans (8). Both PB1 and M1 have adaptation markers linked to increased replication in mammalian cells and increased pathogenicity in mice. The PB1 gene contains a 473D point mutation, which has been found to enhance polymerase activity of avian polymerase in mammalian cells (103). It also encodes a full-length PB1-F2 (8), which is associated with avian viruses, as avian progenitors lose the PB1-F2 open reading frame (ORF) through circulation and adaptation to the mammalian host (104, 105). Loss of PB1-F2 reduces virulence in mammals, leading to the hypothesis that the protein acquires truncations in order to prevent an intense host immune response (106). The JX428 NS1 does not contain a PDZ domain (8). Lack of a PDZ domain is highly unusual (107) and likely to affect virulence (108). The M2 protein contains the amantadine resistance marker 31S (8), which has worrying connotations if a zoonotic H10 were to acquire the ability to be transmitted between human hosts (8).

This novel human H10N3 virus is an avian-origin reassortant strain, with the HA and NA genes from H10N3 viruses and six internal genes from H9N2 poultry viruses, which possess interspecies transmission capability. These pose a very real threat to human health and have pandemic potential; therefore, it is essential to monitor the evolution of H10N3 viruses in Chinese LBMs and domestic birds to provide timely prevention and disease mitigation strategies for these influenza viruses (8).

VACCINATION AND CONTROL

Currently, there are no approved vaccines against H10 AIVs; however, the frequent outbreaks within poultry populations and sporadic introductions, often fatal, into humans have heightened the urgency of precautionary vaccine developments. Investigations into the potential of virus-like particles (VLPs) (109), anti-HA head and anti-HA stalk monoclonal antibodies (110), and the traditional method of inactivated virus vaccine of the outbreak strain (111) have all shown promising protection against the potential lethality of infection in vivo. Additionally, at present, an mRNA vaccine targeting the HA of H10N8 (A/Jiangxi-Donghu/346/2013) has shown promising results following a phase 1 randomized double-blind clinical trial (112).

CONCLUSIONS AND PERSPECTIVES

In recent years, the frequency of detection for H10Nx infections is increasing exponentially. Due to the high reassortant rate between H10 and numerous NA subtypes coupled with the nonnotifiable status of the virus, vast geographical distribution, and lack of sequencing outside Asia and North America, the true extent of H10Nx prevalence could be far higher than currently predicted.

With the increase in human cases, as well as noncontact infections of novel viruses, H10Nx infections continue to pose a threat to both human and animal health. H10 viruses also have endemicity in several regions, sitting across major migratory flyways, meaning that there is a very real threat of increased spread of novel H10Nx infections to both wild birds and domestic poultry and therefore other mammalian species.

Multiple studies have consistently highlighted the ease with which H10Nx viruses are able to reassort with circulating strains (35, 45, 46). Frequent reassortment, coupled with the minimal host adaptation requirements for human infection, clearly identifies H10Nx as posing a pandemic risk. This subtype needs to be subjected to higher levels of surveillance. H10N8 has crossed the species barrier from avian species into both swine and humans, suggesting that this is currently the most effective HA-NA combination for mammalian adaptation. Swine are susceptible to infection with both human and avian influenza viruses, which may undergo reassortment to generate novel reassortant viruses, with swine therefore being considered “mixing vessels” (113). H10N8 has been shown to efficiently replicate in swine and has also caused human fatalities; therefore, N8 is a key subtype to observe closely.

While IAV incursions from avian species to mammalian hosts occur, they are fairly infrequent, with a number of key mutational markers usually present, which are well documented (23). Several H10Nx viruses have been found to alter their PB2 sequence on adaptation to mammalian hosts. E627K has previously been identified as important for mammalian adaptation in other major AIV subtypes (35). In FJ1761 (H10N3) and JX346 (H10N8), E627K resulted in increased virulence in BALB/c mice and enhanced replication in ferrets (35, 45, 114). However, for H10N8 3-9/07, the E627K mutation did not appear to be directly linked to enhanced pathogenesis in BALB/c mice but was instead associated with enhanced polymerase activity (88). Additionally, a serial passage experiment of an H10N7 LPAIV in mice did not produce any PB2 E627K mutations (91). This renders H10Nx viruses unique in their ability to cross the species barrier, as unlike in some other AIV subtypes, E627K appears to be of less importance to avian H10Nx viruses in mammals.

Analysis by Vijaykrishna et al. (43) indicates that the long-term evolutionary dynamics of avian influenza viruses may be determined by climatic changes. Therefore, environmental factors affecting the dynamics of avian influenza should be considered when surveillance and disease control strategies are introduced (43).

Antiviral drugs are widely used to restrict IAV replication in human infections (115, 116). Baloxavir and favipiravir have been shown to be highly effective against numerous IAV subtypes, including H10 (115, 117). The increased emergence of drug-resistant influenza virus strains highlights the need for new antiviral therapeutics to combat future pandemic outbreaks as well as continuing seasonal cycles of influenza (118). While antiviral resistance markers have not yet been identified in H10Nx viruses, this should be closely monitored with the increase in H10 mammalian infections.

Additionally, the need for a formal nomenclature system, with clear and concise lineages in place would allow for greater understanding of the pandemic potential and subsequent risks of emerging H10Nx infections as well as a greater understanding of the distribution, tropism, and infection capabilities of these viruses.

ACKNOWLEDGMENTS

We have no conflicts of interest.

This work was supported by funding from the Biotechnology and Biological Sciences Research Council awards (BB/M011224/1, BBS/E/I/00007032 BBS/E/I/00007039, BB/L018853/1, BB/S013792/1, BB/R012679/1) and the GCRF One Health Poultry Hub award (BB/S011269/1). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Footnotes

Citation Everest H, Billington E, Daines R, Burman A, Iqbal M. 2021. The emergence and zoonotic transmission of H10Nx avian influenza virus infections. mBio 12:e01785-21. https://doi.org/10.1128/mBio.01785-21.

Contributor Information

Munir Iqbal, Email: munir.iqbal@pirbright.ac.uk.

Rohit K. Jangra, Albert Einstein College of Medicine

Vinayaka R. Prasad, Albert Einstein College of Medicine

REFERENCES

  • 1.Wright P, Neumann G, Kawaoka Y. 2013. Orthomyxoviruses. In Knipe D, Howley P (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA. [Google Scholar]
  • 2.Zanaty AM, Erfan AM, Mady WH, Amer F, Nour AA, Rabie N, Samy M, Selim AA, Hassan WMM, Naguib MM. 2019. Avian influenza virus surveillance in migratory birds in Egypt revealed a novel reassortant H6N2 subtype. Avian Res 10:1–10. doi: 10.1186/s40657-019-0180-7. [DOI] [Google Scholar]
  • 3.Hill SC, Hansen R, Watson S, Coward V, Russell C, Cooper J, Essen S, Everest H, Parag KV, Fiddaman S, Reid S, Lewis N, Brookes SM, Smith AL, Sheldon B, Perrins CM, Brown IH, Pybus OG. 2019. Comparative micro-epidemiology of pathogenic avian influenza virus outbreaks in a wild bird population. Philos Trans R Soc Lond B Biol Sci 374:20180259. doi: 10.1098/rstb.2018.0259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wu Y, Wu Y, Tefsen B, Shi Y, Gao GF. 2014. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol 22:183–191. doi: 10.1016/j.tim.2014.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Giotis ES, Carnell G, Young EF, Ghanny S, Soteropoulos P, Wang L-F, Barclay WS, Skinner MA, Temperton N. 2019. Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor. Nat Microbiol 4:2035–2038. doi: 10.1038/s41564-019-0517-3. [DOI] [PubMed] [Google Scholar]
  • 6.Berhane Y, Hisanaga T, Kehler H, Neufeld J, Manning L, Argue C, Handel K, Hooper-McGrevy K, Jonas M, Robinson J, Webster RG, Pasick J. 2009. Highly pathogenic avian influenza virus A (H7N3) in domestic poultry, Saskatchewan, Canada, 2007. Emerg Infect Dis 15:1492–1495. doi: 10.3201/eid1509.080231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fouchier RAM, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SAG, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJJ, Koch G, Bosman A, Koopmans M, Osterhaus ADME. 2004. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 101:1356–1361. doi: 10.1073/pnas.0308352100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wang Y, Niu S, Zhang B, Yang C, Zhou Z. 2021. The whole genome analysis for the first human infection with H10N3 influenza virus in China. J Infect doi: 10.1016/j.jinf.2021.06.021. Epub ahead of print. doi:10.1016/j.jinf.2021.06.021. [DOI] [PubMed] [Google Scholar]
  • 9.Franҫa MS, Brown JD. 2014. Influenza pathobiology and pathogenesis in avian species, p 221–242. Springer International Publishing, New York, NY. [DOI] [PubMed] [Google Scholar]
  • 10.World Health Organization. 2002. WHO manual on animal influenza diagnosis and surveillance. World Health Organization, Geneva, Switzerland. [Google Scholar]
  • 11.World Organisation for Animal Health. 2021. Manual of diagnostic tests and vaccines for terrestrial animals 2021. World Organisation for Animal Health, Paris, France. https://www.oie.int/en/what-we-do/standards/codes-and-manuals/terrestrial-manual-online-access/.
  • 12.Wood GW, Banks J, Strong I, Parsons G, Alexander DJ. 1996. An avian influenza virus of H10 subtype that is highly pathogenic for chickens, but lacks multiple basic amino acids at the haemagglutinin cleavage site. Avian Pathol 25:799–806. doi: 10.1080/03079459608419182. [DOI] [PubMed] [Google Scholar]
  • 13.Post J, de Geus ED, Vervelde L, Cornelissen JBWJ, Rebel JMJ. 2013. Systemic distribution of different low pathogenic avian influenza (LPAI) viruses in chicken. Virol J 10:23. doi: 10.1186/1743-422X-10-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.OIE. 2018. Manual of diagnostic tests and vaccines for terrestrial animals. OIE, Paris, France. [Google Scholar]
  • 15.Baron J, Tarnow C, Mayoli-Nüssle D, Schilling E, Meyer D, Hammami M, Schwalm F, Steinmetzer T, Guan Y, Garten W, Klenk H-D, Böttcher-Friebertshäuser E. 2013. Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses. J Virol 87:1811–1820. doi: 10.1128/JVI.02320-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Foster JE. 2018. Viruses as pathogens: animal viruses affecting wild and domesticated species, p 189–216. In Tennant P, Fermin G, Foster JE (ed), Viruses. Academic Press, New York, NY. [Google Scholar]
  • 17.European Food Safety Authority (EFSA), Gonzales JL, Roberts H, Smietanka K, Baldinelli F, Ortiz-Pelaez A, Verdonck F. 2018. Assessment of low pathogenic avian influenza virus transmission via raw poultry meat and raw table eggs. EFSA J 16:e05431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Horman WSJ, Nguyen THO, Kedzierska K, Bean AGD, Layton DS. 2018. The drivers of pathology in zoonotic avian influenza: the interplay between host and pathogen. Front Immunol 9:1812–1812. doi: 10.3389/fimmu.2018.01812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Iqbal M, Essen SC, Xiao H, Brookes SM, Brown IH, McCauley JW. 2012. Selection of variant viruses during replication and transmission of H7N1 viruses in chickens and turkeys. Virology 433:282–295. doi: 10.1016/j.virol.2012.08.001. [DOI] [PubMed] [Google Scholar]
  • 20.Ma C, Lam TT-Y, Chai Y, Wang J, Fan X, Hong W, Zhang Y, Li L, Liu Y, Smith DK, Webby RJ, Peiris JSM, Zhu H, Guan Y. 2015. Emergence and evolution of H10 subtype influenza viruses in poultry in China. J Virol 89:3534–3541. doi: 10.1128/JVI.03167-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tang L, Tang W, Ming L, Gu J, Qian K, Li X, Wang T, He G. 2020. Characterization of avian influenza virus H10–H12 subtypes isolated from wild birds in Shanghai, China from 2016 to 2019. Viruses 12:1085. doi: 10.3390/v12101085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Mostafa A, Abdelwhab E, Mettenleiter T, Pleschka S. 2018. Zoonotic potential of influenza A viruses: a comprehensive overview. Viruses 10:497. doi: 10.3390/v10090497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Long JS, Mistry B, Haslam SM, Barclay WS. 2019. Host and viral determinants of influenza A virus species specificity. Nat Rev Microbiol 17:67–81. doi: 10.1038/s41579-018-0115-z. [DOI] [PubMed] [Google Scholar]
  • 24.Kayed AS, Kandeil A, Gomaa MR, El-Shesheny R, Mahmoud S, Hegazi N, Fayez M, Sheta B, McKenzie PP, Webby RJ, Kayali G, Ali MA. 2019. Surveillance for avian influenza viruses in wild birds at live bird markets, Egypt, 2014–2016. Influenza Other Respir Viruses 13:407–414. doi: 10.1111/irv.12634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Rimondi A, Gonzalez-Reiche AS, Olivera VS, Decarre J, Castresana GJ, Romano M, Nelson MI, van Bakel H, Pereda AJ, Ferreri L, Geiger G, Perez DR. 2018. Evidence of a fixed internal gene constellation in influenza A viruses isolated from wild birds in Argentina (2006–2016). Emerg Microbes Infect 7:194. doi: 10.1038/s41426-018-0190-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chadha MS, Broor S, Gunasekaran P, Potdar VA, Krishnan A, Chawla-Sarkar M, Biswas D, Abraham AM, Jalgaonkar SV, Kaur H, Klimov A, Lal RB, Moen A, Kant L, Mishra AC. 2012. Multisite virological influenza surveillance in India: 2004–2008. Influenza Other Respir Viruses 6:196–203. doi: 10.1111/j.1750-2659.2011.00293.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sarkar M, Chanda S, Chakrabarti S, Mazumdar J, Ganguly A, Chadha MS, Mishra AC, Chawla-Sarkar M. 2012. Surveillance in eastern India (2007–2009) revealed reassortment event involving ns and PB1-F2 gene segments among co-circulating influenza A subtypes. Virol J 9:3. doi: 10.1186/1743-422X-9-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lycett SJ, Duchatel F, Digard P. 2019. A brief history of bird flu. Philos Trans R Soc Lond B Biol Sci 374:20180257. doi: 10.1098/rstb.2018.0257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Su S, Bi Y, Wong G, Gray GC, Gao GF, Li S. 2015. Epidemiology, evolution, and recent outbreaks of avian influenza virus in China. J Virol 89:8671–8676. doi: 10.1128/JVI.01034-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Everest H, Hill SC, Daines R, Sealy JE, James J, Hansen R, Iqbal M. 2020. The evolution, spread and global threat of H6Nx avian influenza viruses. Viruses 12:673. doi: 10.3390/v12060673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Robinson T, Pozzi F. 2011. Mapping supply and demand for animal-source foods to 2030. FAO Animal Production and Health working paper.
  • 32.World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5N1 Evolution Working Group. 2014. Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses. Influenza Other Respir Viruses 8:384–388. doi: 10.1111/irv.12230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zhuang Q, Wang S, Liu S, Hou G, Li J, Jiang W, Wang K, Peng C, Liu D, Guo A, Chen J. 2019. Diversity and distribution of type A influenza viruses: an updated panorama analysis based on protein sequences. Virol J 16:85. doi: 10.1186/s12985-019-1188-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Liu S, Ji K, Chen J, Tai D, Jiang W, Hou G, Chen J, Li J, Huang B. 2009. Panorama phylogenetic diversity and distribution of type A influenza virus. PLoS One 4:e5022. doi: 10.1371/journal.pone.0005022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Zhang M, Zhang X, Xu K, Teng Q, Liu Q, Li X, Yang J, Xu J, Chen H, Zhang X, Li Z. 2016. Characterization of the pathogenesis of H10N3, H10N7, and H10N8 subtype avian influenza viruses circulating in ducks. Sci Rep 6:34489. doi: 10.1038/srep34489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ito T, Okazaki K, Kawaoka Y, Takada A, Webster RG, Kida H. 1995. Perpetuation of influenza A viruses in Alaskan waterfowl reservoirs. Arch Virol 140:1163–1172. doi: 10.1007/BF01322743. [DOI] [PubMed] [Google Scholar]
  • 37.Khalenkov A, Laver WG, Webster RG. 2008. Detection and isolation of H5N1 influenza virus from large volumes of natural water. J Virol Methods 149:180–183. doi: 10.1016/j.jviromet.2008.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Serena Beato M, Terregino C, Cattoli G, Capua I. 2006. Isolation and characterization of an H10N7 avian influenza virus from poultry carcasses smuggled from China into Italy. Avian Pathol 35:400–403. doi: 10.1080/03079450600920992. [DOI] [PubMed] [Google Scholar]
  • 39.Abolnik C, Gerdes GH, Sinclair M, Ganzevoort BW, Kitching JP, Burger CE, Romito M, Dreyer M, Swanepoel S, Cumming GS, Olivier AJ. 2010. Phylogenetic analysis of influenza A viruses (H6N8, H1N8, H4N2, H9N2, H10N7) isolated from wild birds, ducks, and ostriches in South Africa from 2007 to 2009. Avian Dis 54:313–322. doi: 10.1637/8781-040109-Reg.1. [DOI] [PubMed] [Google Scholar]
  • 40.Woolcock P, Shivaprasad H, De Rosa M. 2000. Isolation of avian influenza virus (H10N7) from an emu (Dromaius novaehollandiae) with conjunctivitis and respiratory disease. Avian Dis 44:737–744. doi: 10.2307/1593122. [DOI] [PubMed] [Google Scholar]
  • 41.Senne D. 2003. Avian influenza in the Western Hemisphere including the Pacific Islands and Australia. Avian Dis 47:798–805. doi: 10.1637/0005-2086-47.s3.798. [DOI] [PubMed] [Google Scholar]
  • 42.Karunakaran D, Hinshaw V, Poss P, Newman J, Halvorson D. 1983. Influenza A outbreaks in Minnesota turkeys due to subtype H10N7 and possible transmission by waterfowl. Avian Dis 27:357–366. doi: 10.2307/1590162. [DOI] [PubMed] [Google Scholar]
  • 43.Vijaykrishna D, Deng Y-M, Su YCF, Fourment M, Iannello P, Arzey GG, Hansbro PM, Arzey KE, Kirkland PD, Warner S, O'Riley K, Barr IG, Smith GJD, Hurt AC. 2013. The recent establishment of North American H10 lineage influenza viruses in Australian wild waterfowl and the evolution of Australian avian influenza viruses. J Virol 87:10182–10189. doi: 10.1128/JVI.03437-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Freidl G, et al. 2014. Influenza at the animal–human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1). Eurosurveillance 19:20793. doi: 10.2807/1560-7917.es2014.19.18.20793. [DOI] [PubMed] [Google Scholar]
  • 45.Schneider EK, Li J, Velkov T. 2017. A portrait of the sialyl glycan receptor specificity of the H10 influenza virus hemagglutinin—a picture of an avian virus on the verge of becoming a pandemic? Vaccines 5:51. doi: 10.3390/vaccines5040051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wu H, Yang F, Liu F, Peng X, Chen B, Cheng L, Lu X, Yao H, Wu N. 2019. Molecular characterization of H10 subtype avian influenza viruses isolated from poultry in Eastern China. Arch Virol 164:159–179. doi: 10.1007/s00705-018-4019-z. [DOI] [PubMed] [Google Scholar]
  • 47.El-Shesheny R, Franks J, Marathe BM, Hasan MK, Feeroz MM, Krauss S, Vogel P, McKenzie P, Webby RJ, Webster RG. 2018. Genetic characterization and pathogenic potential of H10 avian influenza viruses isolated from live poultry markets in Bangladesh. Sci Rep 8:10693. doi: 10.1038/s41598-018-29079-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Zohari S, Metreveli G, Kiss I, Belák S, Berg M. 2010. Full genome comparison and characterization of avian H10 viruses with different pathogenicity in mink (Mustela vison) reveals genetic and functional differences in the non-structural gene. Virol J 7:145. doi: 10.1186/1743-422X-7-145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Pan American Health Organization. 2004. Avian influenza virus A (H10N7) circulating among humans in Egypt. EID Wkly Updates 2(18). https://www.paho.org/en/documents/avian-influenza-virus-h10n7-circulating-among-humans-egypt-vol-2-no-18-7-may-2004. [Google Scholar]
  • 50.Wu H, Lu R, Wu X, Peng X, Xu L, Cheng L, Lu X, Jin C, Xie T, Yao H, Wu N. 2015. Novel reassortant H10N7 avian influenza viruses isolated from chickens in Eastern China. J Clin Virol 65:58–61. doi: 10.1016/j.jcv.2015.02.007. [DOI] [PubMed] [Google Scholar]
  • 51.Ni X, He F, Hu M, Zhou X, Wang B, Feng C, Wu Y, Li Y, Tu J, Li H, Liu M, Chen H, Chen S. 2015. Investigation of avian influenza virus in poultry and wild birds due to novel avian-origin influenza A (H10N8) in Nanchang City, China. Microbes Infect 17:48–53. doi: 10.1016/j.micinf.2014.09.007. [DOI] [PubMed] [Google Scholar]
  • 52.Pusch EA, Suarez DL. 2018. The multifaceted zoonotic risk of H9N2 avian influenza. Vet Sci 5:82. doi: 10.3390/vetsci5040082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.RahimiRad S, Alizadeh A, Alizadeh E, Hosseini SM. 2016. The avian influenza H9N2 at avian-human interface: a possible risk for the future pandemics. J Res Med Sci 21:51. doi: 10.4103/1735-1995.187253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Hu M, Jin Y, Zhou J, Huang Z, Li B, Zhou W, Ren H, Yue J, Liang L. 2017. Genetic characteristic and global transmission of influenza A H9N2 virus. Front Microbiol 8:2611. doi: 10.3389/fmicb.2017.02611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Lam TT-Y, Zhou B, Wang J, Chai Y, Shen Y, Chen X, Ma C, Hong W, Chen Y, Zhang Y, Duan L, Chen P, Jiang J, Zhang Y, Li L, Poon LLM, Webby RJ, Smith DK, Leung GM, Peiris JSM, Holmes EC, Guan Y, Zhu H. 2015. Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature 522:102–105. doi: 10.1038/nature14348. [DOI] [PubMed] [Google Scholar]
  • 56.Chen H, Yuan H, Gao R, Zhang J, Wang D, Xiong Y, Fan GY, Yang F, Li X, Zhou J, Zou S, Yang L, Chen T, Dong L, Bo H, Zhao X, Zhang Y, Lan Y, Bai T, Dong J, Li Q, Wang SW, Zhang Y, Li H, Gong T, Shi Y, Ni X, Li J, Zhou J, Fan J, Wu J, Zhou X, Hu M, Wan J, Yang W, Li DX, Wu G, Feng Z, Gao GF, Wang Y, Jin Q, Liu M, Shu Y. 2014. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet 383:714–721. doi: 10.1016/S0140-6736(14)60111-2. [DOI] [PubMed] [Google Scholar]
  • 57.Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y. 2013. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368:1888–1897. doi: 10.1056/NEJMoa1304459. [DOI] [PubMed] [Google Scholar]
  • 58.Ma W, Kahn RE, Richt JA. 2008. The pig as a mixing vessel for influenza viruses: human and veterinary implications. J Mol Genet Med 3:158–166. [PMC free article] [PubMed] [Google Scholar]
  • 59.Fu X, Huang Y, Fang B, Liu Y, Cai M, Zhong R, Huang J, Wenbao Q, Tian Y, Zhang G. 2020. Evidence of H10N8 influenza virus infection among swine in southern China and its infectivity and transmissibility in swine. Emerg Microbes Infect 9:88–94. doi: 10.1080/22221751.2019.1708811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Wang N, Zou W, Yang Y, Guo X, Hua Y, Zhang Q, Zhao Z, Jin M. 2012. Complete genome sequence of an H10N5 avian influenza virus isolated from pigs in central China. J Virol 86:13865–13866. doi: 10.1128/JVI.02687-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Englund L. 2000. Studies on influenza viruses H10N4 and H10N7 of avian origin in mink. Vet Microbiol 74:101–107. doi: 10.1016/S0378-1135(00)00170-X. [DOI] [PubMed] [Google Scholar]
  • 62.Klingeborn B, Englund L, Rott R, Juntti N, Rockborn G. 1985. An avian influenza A virus killing a mammalian species—the mink. Arch Virol 86:347–351. doi: 10.1007/BF01309839. [DOI] [PubMed] [Google Scholar]
  • 63.Berg M, Englund L, Abusugra IA, Klingeborn B, Linné T. 1990. Close relationship between mink influenza (H10N4) and concomitantly circulating avian influenza viruses. Arch Virol 113:61–71. doi: 10.1007/BF01318353. [DOI] [PubMed] [Google Scholar]
  • 64.Dinter Z. 1949. Eine variante des virus der Geflügelpest in Bayern. Tierärztl Umschau 4:185–186. [Google Scholar]
  • 65.Wood GW, McCauley JW, Bashiruddin JB, Alexander DJ. 1993. Deduced amino acid sequences at the haemagglutinin cleavage site of avian influenza A viruses of H 5 and H 7 subtypes. Arch Virol 130:209–217. doi: 10.1007/BF01319010. [DOI] [PubMed] [Google Scholar]
  • 66.Su S, Qi W, Zhou P, Xiao C, Yan Z, Cui J, Jia K, Zhang G, Gray GC, Liao M, Li S. 2014. First evidence of H10N8 avian influenza virus infections among feral dogs in live poultry markets in Guangdong province, China. Clin Infect Dis 59:748–750. doi: 10.1093/cid/ciu345. [DOI] [PubMed] [Google Scholar]
  • 67.Yamaguchi E, Sashika M, Fujii K, Kobayashi K, Bui VN, Ogawa H, Imai K. 2014. Prevalence of multiple subtypes of influenza A virus in Japanese wild raccoons. Virus Res 189:8–13. doi: 10.1016/j.virusres.2014.05.004. [DOI] [PubMed] [Google Scholar]
  • 68.Hall JS, Bentler KT, Landolt G, Elmore SA, Minnis RB, Campbell TA, Barras SC, Root JJ, Pilon J, Pabilonia K, Driscoll C, Slate D, Sullivan H, McLean RG. 2008. Influenza infection in wild raccoons. Emerg Infect Dis 14:1842–1848. doi: 10.3201/eid1412.071371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Bodewes R, Bestebroer TM, van der Vries E, Verhagen JH, Herfst S, Koopmans MP, Fouchier RAM, Pfankuche VM, Wohlsein P, Siebert U, Baumgärtner W, Osterhaus ADME. 2015. Avian influenza A(H10N7) virus-associated mass deaths among harbor seals. Emerg Infect Dis 21:720–722. doi: 10.3201/eid2104.141675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Krog JS, Hansen MS, Holm E, Hjulsager CK, Chriél M, Pedersen K, Andresen LO, Abildstrøm M, Jensen TH, Larsen LE. 2015. Influenza A(H10N7) virus in dead harbor seals, Denmark. Emerg Infect Dis 21:684–687. doi: 10.3201/eid2104.141484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Lambertz RLO, Gerhauser I, Nehlmeier I, Leist SR, Kollmus H, Pöhlmann S, Schughart K. 2019. Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesis. J Gen Virol 100:1073–1078. doi: 10.1099/jgv.0.001274. [DOI] [PubMed] [Google Scholar]
  • 72.Sakai K, Ami Y, Tahara M, Kubota T, Anraku M, Abe M, Nakajima N, Sekizuka T, Shirato K, Suzaki Y, Ainai A, Nakatsu Y, Kanou K, Nakamura K, Suzuki T, Komase K, Nobusawa E, Maenaka K, Kuroda M, Hasegawa H, Kawaoka Y, Tashiro M, Takeda M. 2014. The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol 88:5608–5616. doi: 10.1128/JVI.03677-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Tarnow C, Engels G, Arendt A, Schwalm F, Sediri H, Preuss A, Nelson PS, Garten W, Klenk H-D, Gabriel G, Böttcher-Friebertshäuser E. 2014. TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice. J Virol 88:4744–4751. doi: 10.1128/JVI.03799-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Abbasi AZ, Kiyani DA, Hamid SM, Saalim M, Fahim A, Jalal N. 2021. Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2. J Med Virol 93:4205–4218. doi: 10.1002/jmv.26911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Belser JA, Katz JM, Tumpey TM. 2011. The ferret as a model organism to study influenza A virus infection. Dis Model Mech 4:575–579. doi: 10.1242/dmm.007823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.O'Donnell CD, Subbarao K. 2011. The contribution of animal models to the understanding of the host range and virulence of influenza A viruses. Microbes Infect 13:502–515. doi: 10.1016/j.micinf.2011.01.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Jia N, Barclay WS, Roberts K, Yen H-L, Chan RWY, Lam AKY, Air G, Peiris JSM, Dell A, Nicholls JM, Haslam SM. 2014. Glycomic characterization of respiratory tract tissues of ferrets: implications for its use in influenza virus infection studies. J Biol Chem 289:28489–28504. doi: 10.1074/jbc.M114.588541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Long JS, Benfield CT, Barclay WS. 2015. One-way trip: influenza virus' adaptation to gallinaceous poultry may limit its pandemic potential. Bioessays 37:204–212. doi: 10.1002/bies.201400133. [DOI] [PubMed] [Google Scholar]
  • 79.Gambaryan AS, Tuzikov AB, Pazynina GV, Desheva JA, Bovin NV, Matrosovich MN, Klimov AI. 2008. 6-Sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry. Virol J 5:85. doi: 10.1186/1743-422X-5-85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Webster RG, Govorkova EA. 2014. Continuing challenges in influenza. Ann N Y Acad Sci 1323:115–139. doi: 10.1111/nyas.12462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Petersen H, Matrosovich M, Pleschka S, Rautenschlein S. 2012. Replication and adaptive mutations of low pathogenic avian influenza viruses in tracheal organ cultures of different avian species. PLoS One 7:e42260. doi: 10.1371/journal.pone.0042260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Nuñez IA, Ross TM. 2019. A review of H5Nx avian influenza viruses. Ther Adv Vaccines Immunother 7:2515135518821625. doi: 10.1177/2515135518821625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Kuchipudi SV, Nelli R, White GA. 2009. Differences in influenza virus receptors in chickens and ducks: implications for interspecies transmission. J Mol Genet Med 03:143. doi: 10.4172/1747-0862.1000026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Costa T, Chaves AJ, Valle R, Darji A, van Riel D, Kuiken T, Majó N, Ramis A. 2012. Distribution patterns of influenza virus receptors and viral attachment patterns in the respiratory and intestinal tracts of seven avian species. Vet Res 43:28. doi: 10.1186/1297-9716-43-28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Kuchipudi SV, Nelli RK, Gontu A, Satyakumar R, Surendran Nair M, Subbiah M. 2021. Sialic acid receptors: the key to solving the enigma of zoonotic virus spillover. Viruses 13:262. doi: 10.3390/v13020262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Gambaryan A, Webster R, Matrosovich M. 2002. Differences between influenza virus receptors on target cells of duck and chicken. Arch Virol 147:1197–1208. doi: 10.1007/s00705-002-0796-4. [DOI] [PubMed] [Google Scholar]
  • 87.Wan H, Perez DR. 2006. Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. Virology 346:278–286. doi: 10.1016/j.virol.2005.10.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Zhang H, Xu B, Chen Q, Chen J, Chen Z. 2011. Characterization of an H10N8 influenza virus isolated from Dongting lake wetland. Virol J 8:42–42. doi: 10.1186/1743-422X-8-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Alexander DJ. 2000. A review of avian influenza in different bird species. Vet Microbiol 74:3–13. doi: 10.1016/S0378-1135(00)00160-7. [DOI] [PubMed] [Google Scholar]
  • 90.Alexander DJ. 2007. An overview of the epidemiology of avian influenza. Vaccine 25:5637–5644. doi: 10.1016/j.vaccine.2006.10.051. [DOI] [PubMed] [Google Scholar]
  • 91.Zhang X, Xu G, Wang C, Jiang M, Gao W, Wang M, Sun H, Sun Y, Chang K-C, Liu J, Pu J. 2017. Enhanced pathogenicity and neurotropism of mouse-adapted H10N7 influenza virus are mediated by novel PB2 and NA mutations. J Gen Virol 98:1185–1195. doi: 10.1099/jgv.0.000770. [DOI] [PubMed] [Google Scholar]
  • 92.Peacock TP, Benton DJ, Sadeyen J-R, Chang P, Sealy JE, Bryant JE, Martin SR, Shelton H, McCauley JW, Barclay WS, Iqbal M. 2017. Variability in H9N2 haemagglutinin receptor-binding preference and the pH of fusion. Emerg Microbes Infect 6:1–7. doi: 10.1038/emi.2016.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Sealy JE, Yaqub T, Peacock TP, Chang P, Ermetal B, Clements A, Sadeyen J-R, Mehboob A, Shelton H, Bryant JE, Daniels RS, McCauley JW, Iqbal M. 2018. Association of increased receptor-binding avidity of influenza A (H9N2) viruses with escape from antibody-based immunity and enhanced zoonotic potential. Emerg Infect Dis 25:63–72. doi: 10.3201/eid2501.180616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Shelton H, Ayora-Talavera G, Ren J, Loureiro S, Pickles RJ, Barclay WS, Jones IM. 2011. Receptor binding profiles of avian influenza virus hemagglutinin subtypes on human cells as a predictor of pandemic potential. J Virol 85:1875–1880. doi: 10.1128/JVI.01822-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Vachieri SG, Xiong X, Collins PJ, Walker PA, Martin SR, Haire LF, Zhang Y, McCauley JW, Gamblin SJ, Skehel JJ. 2014. Receptor binding by H10 influenza viruses. Nature 511:475–477. doi: 10.1038/nature13443. [DOI] [PubMed] [Google Scholar]
  • 96.Wang M, Zhang W, Qi J, Wang F, Zhou J, Bi Y, Wu Y, Sun H, Liu J, Huang C, Li X, Yan J, Shu Y, Shi Y, Gao GF. 2015. Structural basis for preferential avian receptor binding by the human-infecting H10N8 avian influenza virus. Nat Commun 6:5600. doi: 10.1038/ncomms6600. [DOI] [PubMed] [Google Scholar]
  • 97.Zhumatov KK, Kydyrmanov A. 2019. Influenza A/H10 viruses of wild birds, mammals and humans. Eurasian J Appl Biotechnol 2019:15–23. [Google Scholar]
  • 98.van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME, Kuiken T. 2006. H5N1 virus attachment to lower respiratory tract. Science 312:399–399. doi: 10.1126/science.1125548. [DOI] [PubMed] [Google Scholar]
  • 99.Yang J, Zhang T, Guo L, Hu Y, Li J, Su H, Xiao Y, Ren X, Dong J, Sun L, Xiao Y, Li L, Yang F, Wang J, Yuan H, Jin Q. 2014. Mutations of novel influenza A(H10N8) virus in chicken eggs and MDCK cells. Emerg Infect Dis 20:1541–1543. doi: 10.3201/eid2009.140257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Zhang H, de Vries RP, Tzarum N, Zhu X, Yu W, McBride R, Paulson JC, Wilson IA. 2015. A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors. Cell Host Microbe 17:377–384. doi: 10.1016/j.chom.2015.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.de Wit E, Munster VJ, van Riel D, Beyer WEP, Rimmelzwaan GF, Kuiken T, Osterhaus ADME, Fouchier RAM. 2010. Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol 84:1597–1606. doi: 10.1128/JVI.01783-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Herfst S, Zhang J, Richard M, McBride R, Lexmond P, Bestebroer TM, Spronken MIJ, de Meulder D, van den Brand JM, Rosu ME, Martin SR, Gamblin SJ, Xiong X, Peng W, Bodewes R, van der Vries E, Osterhaus ADME, Paulson JC, Skehel JJ, Fouchier RAM. 2020. Hemagglutinin traits determine transmission of avian A/H10N7 influenza virus between mammals. Cell Host Microbe 28:602–613.E7. doi: 10.1016/j.chom.2020.08.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Chen L-M, Blixt O, Stevens J, Lipatov AS, Davis CT, Collins BE, Cox NJ, Paulson JC, Donis RO. 2012. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology 422:105–113. doi: 10.1016/j.virol.2011.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.McAuley JL, Zhang K, McCullers JA. 2010. The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 84:558–564. doi: 10.1128/JVI.01785-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.McAuley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, McCullers JA. 2010. PB1-F2 proteins from H5N1 and 20th century pandemic influenza viruses cause immunopathology. PLoS Pathog 6:e1001014. doi: 10.1371/journal.ppat.1001014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Kamal RP, Kumar A, Davis CT, Tzeng W-P, Nguyen T, Donis RO, Katz JM, York IA. 2015. Emergence of highly pathogenic avian influenza A(H5N1) virus PB1-F2 variants and their virulence in BALB/c mice. J Virol 89:5835–5846. doi: 10.1128/JVI.03137-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Obenauer JC, Denson J, Mehta PK, Su X, Mukatira S, Finkelstein DB, Xu X, Wang J, Ma J, Fan Y, Rakestraw KM, Webster RG, Hoffmann E, Krauss S, Zheng J, Zhang Z, Naeve CW. 2006. Large-scale sequence analysis of avian influenza isolates. Science 311:1576–1580. doi: 10.1126/science.1121586. [DOI] [PubMed] [Google Scholar]
  • 108.Zielecki F, Semmler I, Kalthoff D, Voss D, Mauel S, Gruber AD, Beer M, Wolff T. 2010. Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J Virol 84:10708–10718. doi: 10.1128/JVI.00610-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Pushko P, Sun X, Tretyakova I, Hidajat R, Pulit-Penaloza JA, Belser JA, Maines TR, Tumpey TM. 2016. Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model. Vaccine 34:5235–5242. doi: 10.1016/j.vaccine.2016.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Wohlbold TJ, Chromikova V, Tan GS, Meade P, Amanat F, Comella P, Hirsh A, Krammer F. 2016. Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice. J Virol 90:851–861. doi: 10.1128/JVI.02275-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Suzuki M, Okamatsu M, Fujimoto Y, Hiono T, Matsuno K, Kida H, Sakoda Y. 2018. Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/245/2015 (H10N3) against H10 influenza virus infection in a mouse model. Jpn J Vet Res 66:29–41. [Google Scholar]
  • 112.Feldman RA, Fuhr R, Smolenov I, Mick Ribeiro A, Panther L, Watson M, Senn JJ, Smith M, Almarsson Ö, Pujar HS, Laska ME, Thompson J, Zaks T, Ciaramella G. 2019. mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials. Vaccine 37:3326–3334. doi: 10.1016/j.vaccine.2019.04.074. [DOI] [PubMed] [Google Scholar]
  • 113.Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, Donatelli I, Kida H, Paulson JC, Webster RG, Kawaoka Y. 1998. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72:7367–7373. doi: 10.1128/JVI.72.9.7367-7373.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Liu M, Li X, Yuan H, Zhou J, Wu J, Bo H, Xia W, Xiong Y, Yang L, Gao R, Guo J, Huang W, Zhang Y, Zhao X, Zou X, Chen T, Wang D, Li Q, Wang SWen, Chen S, Hu M, Ni X, Gong T, Shi Y, Li J, Zhou J, Cai J, Xiao Z, Zhang W, Sun J, Li D, Wu G, Feng Z, Wang Y, Chen H, Shu Y. 2015. Genetic diversity of avian influenza A (H10N8) virus in live poultry markets and its association with human infections in China. Sci Rep 5:7632. doi: 10.1038/srep07632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Mishin VP, Patel MC, Chesnokov A, De La Cruz J, Nguyen HT, Lollis L, Hodges E, Jang Y, Barnes J, Uyeki T, Davis CT, Wentworth DE, Gubareva LV. 2019. Susceptibility of influenza A, B, C, and D viruses to baloxavir. Emerg Infect Dis 25:1969–1972. doi: 10.3201/eid2510.190607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Bialy D, Shelton H. 2020. Functional neuraminidase inhibitor resistance motifs in avian influenza A(H5Nx) viruses. Antiviral Res 182:104886. doi: 10.1016/j.antiviral.2020.104886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Daou F, Abou-Sleymane G, Badro DA, Khanafer N, Tobaiqy M, Al Faraj A. 2021. The history, efficacy, and safety of potential therapeutics: a narrative overview of the complex life of COVID-19. Int J Environ Res Public Health 18:955. doi: 10.3390/ijerph18030955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Shin WJ, Seong BL. 2019. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains. Expert Opin Drug Discov 14:153–168. doi: 10.1080/17460441.2019.1560261. [DOI] [PubMed] [Google Scholar]

Articles from mBio are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES